SCHEMBL7988271

SCHEMBL7988271

O=C(C(Cl)(Cl)c1ccncc1)C(Cl)(Cl)c1ccncc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.43
NAPRT Q6XQN6 1/20 0.41
USP2 O75604 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 1/20 0.38
MDM2 Q00987 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2C9 P11712 1/20 0.36
KDM4E B2RXH2 2/20 0.35
JUN P05412 1/20 0.35
NFKB1 P19838 1/20 0.35
MPO P05164 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2A6 P11509 1/20 0.35
P2RX7 Q99572 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987418 0.75 CYP1A2 (0.58) NAPRTALDH1A1KMT2ACYP1A2CYP2C19
SCHEMBL28320267 0.72 CYP19A1 (0.43) CYP19A1NAPRTUSP2RAB9AALDH1A1
SCHEMBL29091784 0.71 KIF11 (0.54) CYP19A1NAPRTUSP2RAB9ACYP1A2
SCHEMBL5720583 0.71 TSHR (0.50) CYP19A1USP2RAB9AALDH1A1MEN1
SCHEMBL7265049 0.69 CYP19A1 (0.44) CYP19A1USP2RAB9AALDH1A1MEN1
SCHEMBL20412356 0.68 NAPRT (0.48) CYP19A1NAPRTUSP2RAB9AALDH1A1
SCHEMBL27610091 0.68 CYP19A1 (0.50) CYP19A1NAPRTUSP2RAB9AALDH1A1
SCHEMBL16886277 0.68 CYP19A1 (0.51) CYP19A1NAPRTUSP2RAB9AKMT2A
SCHEMBL12909254 0.67 KIF11 (0.48) CYP19A1USP2RAB9AALDH1A1MEN1
SCHEMBL14486637 0.67 KIF11 (0.46) CYP19A1USP2RAB9AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6255326-B1 ANTIINFLAMMATORY AGENT; AUTOIMMUNE DISEASES AVENTIS PHARMA LIMITED (GB) 2001-07-03 US disclosed